Status:

RECRUITING

Study of Lung Proteins in Patients With Pneumonia

Lead Sponsor:

National Institutes of Health Clinical Center (CC)

Conditions:

Pneumonia

Pulmonary Disease

Eligibility:

All Genders

3-99 years

Brief Summary

This study will examine the different types of proteins present in the lungs of patients with pneumonia to explore the causes of different types of the disease. Pneumonia is a condition that causes lu...

Detailed Description

OBJECTIVE: The objective of this study is to analyze bronchoalveolar lavage (BAL) fluid from patients with lung infiltrates in order to discover new biomarkers and protein/peptide expression patterns...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • All eligible patients undergoing diagnostic bronchoscopy who provide consent for proteomic analysis of BAL fluid supernatant and chart review of patient characteristics will be included in this study.
  • A parent/guardian may provide consent for a child age 17 or under and a Legally Authorized Representative (LAR) may provide consent for adults unable to consent.
  • EXCLUSION CRITERIA:
  • Patients undergoing bronchoscopy but not wanting to participate with either the chart review or the proteomic analysis of BAL fluid supernatant will be excluded.

Exclusion

    Key Trial Info

    Start Date :

    February 20 2004

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    Estimated Enrollment :

    750 Patients enrolled

    Trial Details

    Trial ID

    NCT00077909

    Start Date

    February 20 2004

    Last Update

    December 24 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    National Institutes of Health Clinical Center

    Bethesda, Maryland, United States, 20892

    Study of Lung Proteins in Patients With Pneumonia | DecenTrialz